Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre
Background. Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with localized cutaneous melanoma. The National Comprehensive Cancer Network (NCCN) Melanoma Panel has reinforced the status of the sentinel lymph node (SLN) as an important prognostic factor for melanoma survival. We...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Journal of Skin Cancer |
| Online Access: | http://dx.doi.org/10.1155/2013/904701 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561974144139264 |
|---|---|
| author | Vera Teixeira Ricardo Vieira Inês Coutinho Rita Cabral David Serra Maria José Julião Maria Manuel Brites Anabela Albuquerque João Pedroso de Lima Américo Figueiredo |
| author_facet | Vera Teixeira Ricardo Vieira Inês Coutinho Rita Cabral David Serra Maria José Julião Maria Manuel Brites Anabela Albuquerque João Pedroso de Lima Américo Figueiredo |
| author_sort | Vera Teixeira |
| collection | DOAJ |
| description | Background. Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with localized cutaneous melanoma. The National Comprehensive Cancer Network (NCCN) Melanoma Panel has reinforced the status of the sentinel lymph node (SLN) as an important prognostic factor for melanoma survival. We sought to identify predictive factors associated with a positive SLNB and overall survival in our population. Methods. We performed a retrospective chart review of 221 patients who have done a successful SLNB for melanoma between 2004 and 2010 at our department. Univariate and multivariate analyses were done. Results. The SLNB was positive in 48 patients (21.7%). Univariate analysis showed that male gender, increasing Breslow thickness, tumor type, and absence of tumor-infiltrating lymphocytes were significantly associated with a positive SLNB. Multivariate analysis confirmed that Breslow thickness and the absence of tumor-infiltrating lymphocytes are independently predictive of SLN metastasis. The 5-year survival rates were 53.1% for SLN positive patients and 88.2% for SLN negative patients. Breslow thickness and the SLN status independently predict overall survival. Conclusions. The risk factors for a positive SLNB are consistent with those found in the previous literature. In addition, the SLN status is a major determinant of survival, which highlights its importance in melanoma management. |
| format | Article |
| id | doaj-art-57c3c235a089433c9d95550ed8cc9daa |
| institution | Kabale University |
| issn | 2090-2905 2090-2913 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Skin Cancer |
| spelling | doaj-art-57c3c235a089433c9d95550ed8cc9daa2025-02-03T01:23:47ZengWileyJournal of Skin Cancer2090-29052090-29132013-01-01201310.1155/2013/904701904701Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma CentreVera Teixeira0Ricardo Vieira1Inês Coutinho2Rita Cabral3David Serra4Maria José Julião5Maria Manuel Brites6Anabela Albuquerque7João Pedroso de Lima8Américo Figueiredo9Dermatology Department, Coimbra University Hospital, Praceta Mota Pinto, 3000-075 Coimbra, PortugalDermatology Department, Coimbra University Hospital, Praceta Mota Pinto, 3000-075 Coimbra, PortugalDermatology Department, Coimbra University Hospital, Praceta Mota Pinto, 3000-075 Coimbra, PortugalDermatology Department, Coimbra University Hospital, Praceta Mota Pinto, 3000-075 Coimbra, PortugalDermatology Department, Coimbra University Hospital, Praceta Mota Pinto, 3000-075 Coimbra, PortugalPathology Department, Coimbra University Hospital, 3000-075 Coimbra, PortugalDermatology Department, Coimbra University Hospital, Praceta Mota Pinto, 3000-075 Coimbra, PortugalNuclear Medicine Department, Coimbra University Hospital, 3000-075 Coimbra, PortugalFaculty of Medicine, University of Coimbra, 3000-075 Coimbra, PortugalDermatology Department, Coimbra University Hospital, Praceta Mota Pinto, 3000-075 Coimbra, PortugalBackground. Sentinel lymph node biopsy (SLNB) is a standard procedure for patients with localized cutaneous melanoma. The National Comprehensive Cancer Network (NCCN) Melanoma Panel has reinforced the status of the sentinel lymph node (SLN) as an important prognostic factor for melanoma survival. We sought to identify predictive factors associated with a positive SLNB and overall survival in our population. Methods. We performed a retrospective chart review of 221 patients who have done a successful SLNB for melanoma between 2004 and 2010 at our department. Univariate and multivariate analyses were done. Results. The SLNB was positive in 48 patients (21.7%). Univariate analysis showed that male gender, increasing Breslow thickness, tumor type, and absence of tumor-infiltrating lymphocytes were significantly associated with a positive SLNB. Multivariate analysis confirmed that Breslow thickness and the absence of tumor-infiltrating lymphocytes are independently predictive of SLN metastasis. The 5-year survival rates were 53.1% for SLN positive patients and 88.2% for SLN negative patients. Breslow thickness and the SLN status independently predict overall survival. Conclusions. The risk factors for a positive SLNB are consistent with those found in the previous literature. In addition, the SLN status is a major determinant of survival, which highlights its importance in melanoma management.http://dx.doi.org/10.1155/2013/904701 |
| spellingShingle | Vera Teixeira Ricardo Vieira Inês Coutinho Rita Cabral David Serra Maria José Julião Maria Manuel Brites Anabela Albuquerque João Pedroso de Lima Américo Figueiredo Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre Journal of Skin Cancer |
| title | Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre |
| title_full | Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre |
| title_fullStr | Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre |
| title_full_unstemmed | Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre |
| title_short | Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre |
| title_sort | prediction of sentinel node status and clinical outcome in a melanoma centre |
| url | http://dx.doi.org/10.1155/2013/904701 |
| work_keys_str_mv | AT verateixeira predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT ricardovieira predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT inescoutinho predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT ritacabral predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT davidserra predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT mariajosejuliao predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT mariamanuelbrites predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT anabelaalbuquerque predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT joaopedrosodelima predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre AT americofigueiredo predictionofsentinelnodestatusandclinicaloutcomeinamelanomacentre |